Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("HAFERLACH, T")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 51

  • Page / 3
Export

Selection :

  • and

Multiple myeloma first presenting as cutaneous plasmacytomaHAUSCHILD, A; HAFERLACH, T; LÖFFLER, H et al.Journal of the American Academy of Dermatology. 1996, Vol 34, Num 1, pp 146-148, issn 0190-9622Article

Endodermaler Sinustumor (Dottersacktumor) des vorderen MediastinumsSÖTJE, G; SCHRÖDER, D; HAFERLACH, T et al.Röntgen-Blätter. 1990, Vol 43, Num 11, pp 457-460, issn 0300-8592Article

Interactive diagnostics in the indication to allogeneic SCT in AMLBACHER, U; HAFERLACH, C; SCHNITTGER, S et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 10, pp 745-756, issn 0268-3369, 12 p.Article

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCGLENGFELDER, E; HAFERLACH, C; KERN, W et al.Leukemia. 2009, Vol 23, Num 12, pp 2248-2258, issn 0887-6924, 11 p.Article

New insights into MLL gene rearranged acute leukemias using gene expression profiling : shared pathways, lineage commitment, and partner genesKOHLMANN, A; SCHOCH, C; DUGAS, M et al.Leukemia. 2005, Vol 19, Num 6, pp 953-964, issn 0887-6924, 12 p.Article

Multivariate analysis of prognostic factors in patients with refractory and relapsed acute myeloid leukemia undergoing sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy : relevance of cytogenetic abnormalitiesKERN, W; SCHOCH, C; HAFERLACH, T et al.Leukemia. 2000, Vol 14, Num 2, pp 226-231, issn 0887-6924Article

Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantationGLASS, B; MAJOLINO, I; DREGER, P et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 7, pp 533-541, issn 0268-3369Article

Glass slide smears are a suitable source for RT-PCR-based analysis of chromosomal aberrations in leukaemiasSCHOCH, R; JENISCH, S; HAFERLACH, T et al.British journal of haematology. 1996, Vol 92, Num 1, pp 140-142, issn 0007-1048Article

Secondary acute leukaemias with 11q23 rearrangement : clinical, cytogenetic, FISH and FICTION studiesYANMING ZHANG; POETSCH, M; WEBER-MATTHIESEN, K et al.British journal of haematology. 1996, Vol 92, Num 3, pp 673-680, issn 0007-1048Article

High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD)SCHMITZ, N; PRANGE, E; HAFERLACH, T et al.Bone marrow transplantation (Basingstoke). 1991, Vol 8, Num 6, pp 503-506, issn 0268-3369Article

Impact of physiological BM CD10 + CD19 + B-cell precursors (haematogones) in the post-transplant period in patients with AMLCHRISTOPEIT, M; HEILAND, A; BINDER, M et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 9, pp 1257-1259, issn 0268-3369, 3 p.Article

Landscape of TET2 mutations in acute myeloid leukemiaWEISSMANN, S; ALPERMANN, T; KERN, W et al.Leukemia. 2012, Vol 26, Num 5, pp 934-942, issn 0887-6924, 9 p.Article

The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AMLHAFERLACH, C; BACHER, U; HAFERLACH, T et al.Leukemia. 2011, Vol 25, Num 5, pp 874-877, issn 0887-6924, 4 p.Article

AML with CBFB-MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletionsHAFERLACH, C; DICKER, F; KOHLMANN, A et al.Leukemia. 2010, Vol 24, Num 5, pp 1065-1069, issn 0887-6924, 5 p.Article

Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count : a study on 162 patientsSCHNITTGER, S; BACHER, U; HAFERLACH, C et al.Leukemia. 2007, Vol 21, Num 4, pp 725-731, issn 0887-6924, 7 p.Article

Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemiaWUCHTER, C; KARAWAJEW, L; LUDWIG, W.-D et al.Haematologica (Roma). 2000, Vol 85, Num 7, pp 711-721, issn 0390-6078Article

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemiaLENGFELDER, E; REICHERT, A; FONATSCH, C et al.Leukemia. 2000, Vol 14, Num 8, pp 1362-1370, issn 0887-6924Article

Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogeneticsWUCHTER, C; KARAWAJEW, L; RUPPERT, V et al.Leukemia. 1999, Vol 13, Num 12, pp 1943-1953, issn 0887-6924Article

Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniquesHAFERLACH, T; WINKEMANN, M; GASSMANN, W et al.British journal of haematology. 1997, Vol 97, Num 1, pp 99-106, issn 0007-1048Article

High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's diseaseSCHMITZ, N; GLASS, B; DREGER, P et al.Annals of hematology (Print). 1993, Vol 66, Num 5, pp 251-256, issn 0939-5555Article

Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemiaSCHNITTGER, S; BACHER, U; KERN, W et al.Leukemia. 2011, Vol 25, Num 8, pp 1297-1304, issn 0887-6924, 8 p.Article

The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1JENAL, M; BATLINER, J; REDDY, V. A et al.Leukemia. 2010, Vol 24, Num 5, pp 1073-1076, issn 0887-6924, 4 p.Article

NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis : de-novo origin?PASQUALUCCI, L; LI, S; HAFERLACH, T et al.Leukemia. 2008, Vol 22, Num 7, pp 1459-1463, issn 0887-6924, 5 p.Article

Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networksSTAAL, F. J. T; CARIO, G; VAN DONGEN, J. J. M et al.Leukemia. 2006, Vol 20, Num 8, pp 1385-1392, issn 0887-6924, 8 p.Article

Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETOKUCHENBAUER, F; SCHNITTGER, S; LOOK, T et al.British journal of haematology. 2006, Vol 134, Num 6, pp 616-619, issn 0007-1048, 4 p.Article

  • Page / 3